We are live on ! Find out more
AGRX

Agile Therapeutics
AGRX

Delisted

AGRX was delisted on the 25th of March, 2024.

Back to rankings

51 hedge funds and large institutions have $167M invested in Agile Therapeutics in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

2% more funds holding

Funds holding: 50 → 51 (+1)

9% less capital invested

Capital invested by funds: $184M → $167M (-$16.8M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
6
Increased
11
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$4.15M
2
PA
Perceptive Advisors
New York
+$3.61M
3
CC
Caxton Corporation
New Jersey
+$1.38M
4
HLA
Hamilton Lane Advisors
Pennsylvania
+$400K
5
BCM
Bridgeway Capital Management
Texas
+$385K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$6.49M
2
SAM
Senzar Asset Management
New York
-$2.75M
3
AC
Aisling Capital
New York
-$2.2M
4
RA
Royce & Associates
New York
-$614K
5
JGC
J. Goldman & Co
New York
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMAG
26
Pinnacle Wealth Management Advisory Group
New Jersey
$350K -$186K -13 -34%
BIM
27
BlackRock Investment Management
Delaware
$318K – – –
NIM
28
Needham Investment Management
New York
$314K +$328K +23 New
FLAM
29
First Light Asset Management
Minnesota
$261K -$157K -11 -37%
COPPSERS
30
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$215K – – –
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$194K -$99.9K -7 -33%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$194K – – –
AP
33
AlpInvest Partners
Netherlands
$193K – – –
RHJA
34
Rice Hall James & Associates
California
$179K – – –
PVI
35
Pura Vida Investments
New York
$174K +$171K +12 New
HCMT
36
Highland Capital Management (Texas)
Texas
$169K +$171K +12 New
Renaissance Technologies
37
Renaissance Technologies
New York
$144K +$143K +10 New
TA
38
Teachers Advisors
New York
$135K – – –
BFM
39
Boothbay Fund Management
New York
$103K +$99.9K +7 New
Charles Schwab
40
Charles Schwab
California
$94K – – –
TC
41
TFS Capital
Pennsylvania
$73K -$85.6K -6 -55%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$66K – – –
GT
43
Glenmede Trust
Pennsylvania
$65K – – –
NFA
44
Nationwide Fund Advisors
Ohio
$56K – – –
Morgan Stanley
45
Morgan Stanley
New York
$55K +$28.5K +2 +100%
AIG
46
American International Group
New York
$53.4K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$34K – – –
BA
48
BlackRock Advisors
Delaware
$31K – – –
Wells Fargo
49
Wells Fargo
California
$31K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$14K – – –
1
2
3

AGRX Hedge Fund Activity: Q3 2016 in Review

51 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q3 2016, worth a combined $167M — down 9.1% from $184M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AGRX positions and 5 closed out — a net gain of 1 holder — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Invesco, adding an estimated $4.15M. The largest seller was RA Capital Management, exiting entirely with an estimated $6.49M sold.

  • 51 institutional investors held Agile Therapeutics (AGRX) as of Q3 2016, up from 50 in Q2 2016.
  • Funds reported $167M of Agile Therapeutics stock for Q3 2016, down 9.1% quarter-over-quarter.
  • 6 funds opened new Agile Therapeutics positions in Q3 2016 and 5 closed out, a net change of +1 holder.
  • The largest Agile Therapeutics buyer in Q3 2016 was Invesco, an estimated $4.15M added.
  • The largest Agile Therapeutics seller in Q3 2016 was RA Capital Management, an estimated $6.49M sold.

Based on aggregated 13F filings for Q3 2016.